#esmo19: prima/engot-ov26/gog-3012 positive study for ovarian cancer
Published 4 years ago • 859 plays • Length 7:05Download video MP4
Download video MP3
Similar videos
-
6:56
#esmo19: positive trial for ovarian cancer: paola-1/engot-ov25
-
4:46
#esmo19: forward i (gog 3011) study for platinum-resistant ovarian cancer
-
6:12
#esmo19: positive trial for ovarian cancer: velia (gog 3005)
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
4:34
niraparib in newly diagnosed advanced ovarian cancer: prima results
-
4:06
clinical data from the phase iii prima trial
-
0:53
gynecologic oncology at asco 2018: ovarian cancer, jcog0602, onda
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
0:58
society of gynecologic oncology 50th anniversary: adrienne mallen, md
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
26:47
2014 society of gynecologic oncology meeting: ovarian cancer
-
2:34
gynecologic oncology research at asco 2017: icon6 ovarian cancer trial
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer
-
2:03
on the scene at #sgomtg: ovarian cancer research highlights
-
1:34
dr. gonzalez-martin on the impact of the prima trial in advanced ovarian cancer
-
23:13
88th gynecologic oncology group meeting: ovarian cancer
-
2:27
the paola-1 study: olaparib and bevacizumab for ovarian cancer
-
12:07
gynecologic oncology at asco21: novel targets in recurrent ovarian cancer